Shape a clear scientific communication strategy
Generate and structure robust scientific evidence
Track the health data
that truly matters
Trusted by
Evidence infrastructure
for Digital Health
“Extraordinary claims require extraordinary evidence” - but startup operators don’t have time to manage the agonizing plod of peer-reviewed publishing. If you don’t know where you sit in the evidence landscape, can’t prove that your product delivers, or don’t have a strategy for producing extraordinary evidence to overcome objections, get ProofStack.
Shape a clear scientific communication strategy
Start with a competitive scientific literature landscape scan — benchmark up to 5 rivals on citation counts, publication velocity, and research focus. SciComms infrastructure to uncover your edge and define a roadmap for moving from scattered efforts to strategic impact.
Generate and structure robust scientific evidence
We help translate your science into action with SWOT analysis, SciComms policies, SOPs, and a publishing bootcamp. Whether you're seed stage or scaling, we’ll join your team to plan and produce credible evidence that builds trust and unlocks growth.
Track the health data that truly matters
From peer-reviewed publications to press releases, we guide you in selecting, measuring, and communicating the data that drives clinical and commercial outcomes. Our support spans conference strategy, journal submissions, and turning scientific outputs into high-impact B2B materials.
“Paul brings a rare blend of scientific depth, operational knowledge, patient focused expertise and strategic clarity to every opportunity.”
John Reites
Co-Founder and CEO at Thread Research
200+
peer-reviewed publications
40+
clients achieved publications*
5+
editorial boards incl The BMJ
*Publications in
Who is this for?
🎯 Founders
Seeking to build customer-grade evidence
🧠 Chief Medical Officers
Translating science into advantage
💸 Investors
Looking to de-risk their portfolio companies with signal
Paul Wicks, PHD.
Paul is a neuropsychologist and expert in digital health, clinical trials, and patient centricity. For 13 years he led the R&D team at PatientsLikeMe, an online community for over 850,000 people living with medical conditions.
Specialising in clinical research using the Internet, Paul shaped the scientific validity of the platform in generating insights from patient-generated health data, and has published over 200 studies including a patient-driven observational trial of lithium in ALS, numerous patient-reported outcome measures, a “dose-response” curve for the benefits of friendship between patients, and methods for patient-centered and virtual clinical trial designs.
He has sat on the editorial boards of the BMJ, BMC Medicine, JMIR, Digital Biomarkers, The Patient, and BMJ Digital Health & AI. Prior to joining PatientsLikeMe, Paul worked at the Institute of Psychiatry (King’s College London) studying cognition and neuroimaging in ALS, with a postdoc in psychological consequences of Parkinson’s disease.
His work has been profiled by the BBC, NPR, CNN, BBC Radio 4, the Wall Street Journal, and the New York Times. In 2011 he was awarded MIT Technology Review’s TR35 “Humanitarian of the Year” award, recognized as a TED Fellow in 2012, and joined the inaugural FLIER Program at the Academy of Medical Sciences in 2019.
Speaking
From keynotes described as "the highlight of the conference" to corporate workshops, we can offer transformative talks on digital innovation, inspirational citizen science, and the future of health. Paul has spoken on global stages including TED, Lift!, and the G8, and spoken for corporate clients in finance, life sciences, and consulting.